On 10/20/25, Avalo Therapeutics Inc (NASDAQ: AVTX) stock enjoyed a major increase of 11.2%, closing at $17.08. Moreover, this advance was accompanied by exceptionally high trading volume at 215% of normal. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 22.4% during the last week.
Current PriceTarget Research Rating
Avalo Therapeutics has a current Value Trend Rating of A (Highest Rating). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. Avalo Therapeutics has a neutral Appreciation Score of 56 but a good Power Rating of 85, resulting in the Highest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of A. This review will be completed in the next several days.
Be the first to comment